Absorption of Folic Acid from a Softgel Capsule Compared to a Standard Tablet

Journal of the Academy of Nutrition and Dietetics

Volumn 112, Issue 7, 2012, Pages 1062-1067

  Maki, Kevin C ^a   Ndife, Louis I ^b   Kelley, Kathleen M ^a   Lawless, Andrea L ^a   Brooks, James R ^b   Wright, Shannon B ^b   Shields, Jocelyn M ^a   Dicklin, Mary R ^a  

^a Biofortis Clinical Research   (United States)

^b Pharmavite LLC   (United States)

Author keywords

Bioavailability; Folic acid; Multivitamins; Softgel capsules

Indexed keywords

FOLIC ACID;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; AREA UNDER THE CURVE; ARTICLE; BIOAVAILABILITY; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; HUMAN; INTESTINE ABSORPTION; MICROCAPSULE; MIDDLE AGED; NEURAL TUBE DEFECT; RANDOMIZED CONTROLLED TRIAL; TABLET;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CAPSULES; CROSS-OVER STUDIES; FEMALE; FOLIC ACID; HUMANS; INTESTINAL ABSORPTION; MIDDLE AGED; NEURAL TUBE DEFECTS; TABLETS; YOUNG ADULT;

EID: 84862661568     PISSN: 22122672     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jand.2012.03.001     Document Type: Article

References (50)

1. Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study. Lancet 1991, 338(8760):131-137. Medical Research Council Vitamin Study Research Group.
2. 12, Pantothenic Acid, Biotin, and Choline. A report of the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes and its Panel on Folate, Other B Vitamins, and Choline and Subcommittee on Upper Reference Levels of Nutrients 1998, 196-305. Food and Nutrition Board, Institute of Medicine, National Academies Press, Washington, DC.
3. Tamura T., Picciano M.F. Folate and human reproduction. Am J Clin Nutr 2006, 83(5):993-1016.
4. Wolff T., Witkop C.T., Miller T., Syed S.B. Folic acid supplementation for the prevention of neural tube defects: An update of the evidence for the US Preventive Services Task Force 2009 May, Agency for Healthcare Research and Quality, Rockville, MD, (Evidence Syntheses, no. 70).
5. Blencowe H., Cousens S., Modell B., Lawn J. Folic acid to reduce neonatal mortality from neural tube disorders. Int J Epidemiol 2010, 39(suppl 1):i110-i121.
6. Czeizel A.E., Dudás I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992, 327(26):1832-1835.
7. Wolff T., Witkop C.T., Miller T., Syed S.B. Folic acid supplementation for the prevention of neural tube defects: An update of the evidence for the US Preventive Services Task Force. Ann Intern Med 2009, 150(9):632-639. US Preventive Services Task Force.
8. Sauberlich H.E., Kretsch M.J., Skala J.H., Johnson H.L., Taylor P.C. Folate requirement and metabolism in nonpregnant women. Am J Clin Nutr 1987, 46(6):1016-1028.
9. Food standards: Amendment of standards of identity for enriched grain products to require addition of folic acid: Final rule, (21 CFR Parts 136, 137, 139). Fed Reg 1996, 61:8781-8797. US Food and Drug Administration.
10. Regulations amending the Food and Drug Regulations, Schedule No. 1066. Canada Gazette 1997, 131:1509-1519. Health Canada, Part 1, Accessed November 25, 2011. http://www.gazette.gc.ca/archives/p2/1998/1998-11-25/html/sor-dors550-eng.html.
11. Evaluation of food fortification with folic acid for the primary prevention of neural tube defects. Executive Summary 1997-2003 Public Health Agency of Canada, Accessed November 25, 2011. http://www.phac-aspc.gc.ca/publicat/faaf/pdf/folic_acid_e.pdf.
12. McNulty H., Pentieva K. Folate bioavailability. Proc Nutr Soc 2004, 63(4):529-536.
13. McNulty H., Scott J.M. Intake and status of folate and related B-vitamins: Considerations and challenges in achieving optimal status. Br J Nutr 2008, 99(suppl 3):S48-S54.
14. Lawrence M.A., Chai W., Kara R., Rosenberg I.H., Scott J., Tedstone A. Examination of selected national policies towards mandatory folic acid fortification. Nutr Rev 2009, 67(suppl 1):S73-S78.
15. Tinker S.C., Cogswell M.E., Devine O., Berry R.J. Folic acid intake among US women aged 15-44 years, National Health and Nutrition Examination Survey, 2003-2006. Am J Prev Med 2010, 38(5):534-542.
16. Jones W.J., Francis J.J. Softgels: Consumer perceptions and market impact relative to other oral dosage forms. Adv Ther 2000, 17(5):213-221.
17. Hoag S.W., Ramachandruni H., Shangraw R.F. Failure of prescription prenatal vitamin products to meet USP standards for folic acid dissolution. J Am Pharm Assoc (Wash.) 1997, NS37(4):397-400.
18. Giebe K., Counts C. Comparison of Prenate Advance with other prescription prenatal vitamins: A folic acid dissolution study. Adv Ther 2000, 17(4):179-183.
19. Sculthorpe N.F., Davies B., Ashton T., Allison S., McGuire D.N., Malhi J.S. Commercially available folic acid supplements and their compliance with the British Pharmacopoeia test for dissolution. J Public Health Med 2001, 23(3):195-197.
20. Srinivasan V.S. Bioavailability of nutrients: A practical approach to in vitro demonstration of the availability of nutrients in multivitamin-mineral combination products. J Nutr 2001, 131(4 suppl):1349S-1350S.
21. Du J., Hoag S.W. Characterization of excipient and tableting factors that influence folic acid dissolution, friability, and breaking strength of oil-and water-soluble multivitamin with minerals tablets. Drug Dev Ind Pharm 2003, 29(10):1137-1147.
22. Melse-Boonstra A., West C.E., Katan M.B., Kok F.J., Verhoef P. Bioavailability of heptaglutamyl relative to monoglutamyl folic acid in healthy adults. Am J Clin Nutr 2004, 79(3):424-429.
23. Pentieva K., McNulty H., Reichert R., et al. The short-term bioavailabilities of [6S]-5-methyltetrahydrofolate and folic acid are equivalent in men. J Nutr 2004, 134(3):580-585.
24. Löbenberg R., Steinke W. Investigation of vitamin and mineral tablets and capsules on the Canadian market. J Pharm Pharm Sci 2006, 9(1):40-49.
25. Yetley E.A. Multivitamin and multimineral dietary supplements: Definitions, characterization, bioavailability, and drug interactions. Am J Clin Nutr 2007, 85(1):269S-276S.
26. Hartman-Craven B., Christofides A., O'Connor D.L., Zlotkin S. Relative bioavailability of iron and folic acid from a new powdered supplement compared to a traditional tablet in pregnant women. BMC Pregnancy Childbirth 2009, 9:33.
27. Younis I.R., Stamatakis M.K., Callery P.S., Meyer-Stout P.J. Influence of pH on the dissolution of folic acid supplements. Int J Pharm 2009, 367(1-2):97-102.
28. Póo-Prieto R., Haytowitz D.B., Holden J.M., et al. Use of the affinity/HPLC method for quantitative estimation of folic acid in enriched cereal-grain products. J Nutr 2006, 136(12):3079-3083.
29. Brouns F., Bjorck I., Frayn K.N., et al. Glycaemic index methodology. Nutr Res Rev 2005, 18(1):145-171.
30. Shapiro S.S., Wilk M.B. An analysis of variance test for normality (complete samples). Biometrika 1965, 52(3-4):591-611.
31. Ghishan F.K., Said H.M., Wilson P.C., Murrell J.E., Greene H.L. Intestinal transport of zinc and folic acid: A mutual inhibitory effect. Am J Clin Nutr 1986, 43(2):258-262.
32. Kauwell G.P., Bailey L.B., Gregory J.F., Bowling D.W., Cousins R.J. Zinc status is not adversely affected by folic acid supplementation and zinc intake does not impair folate utilization in human subjects. J Nutr 1995, 125(1):66-72.
33. Keating J.N., Wada L., Stokstad E.L., King J.C. Folic acid: Effect on zinc absorption in humans and in the rat. Am J Clin Nutr 1987, 46(5):835-839.
34. Butterworth C.E., Tamura T. Folic acid safety and toxicity: A brief review. Am J Clin Nutr 1989, 50(2):353-358.
35. Hoag S.W., Hussain A.S. The impact of formulation on bioavailability: Summary of workshop discussion. J Nutr 2001, 131(4 suppl):1389S-1391S.
36. Oner L., Arcasoy A., Kas H.S., Hincal A.A. Studies on zinc sulphate microcapsules: (III) In vivo evaluation. Eur J Drug Metab Pharmacokinet 1989, 14(2):107-110.
37. Bhagavan H.N., Wolkoff B.I. Correlation between the disintegration time and the bioavailability of vitamin C tablets. Pharm Res 1993, 10(2):239-242.
38. Simmons W.K., Cook J.D., Bingham K.C., et al. Evaluation of a gastric delivery system for iron supplementation in pregnancy. Am J Clin Nutr 1993, 58(5):622-626.
39. Navarro M., Wood R.J. Plasma changes in micronutrients following a multivitamin and mineral supplement in healthy adults. J Am Coll Nutr 2003, 22(2):124-132.
40. The United States Pharmacopeial Convention 2010. {2040} Disintegration and dissolution of dietary supplements. Revision bulletin. Official March 2, 2010 Accessed December 19, 2010. http://www.usp.org/pdf/EN/USPNF/gc2040DisintegrationAnd%20DissolutionDS.pdf.
41. Pietrzik K., Bailey L., Shane B. Folic acid and L-methyltetrahydrofolate: Comparison of clinical pharmacokinetics and pharmacodynamics. Clin Pharmacokinet 2010, 49(8):535-548.
42. Whitehead V.M., Cooper B.A. Absorption of unaltered folic acid from the gastro-intestinal tract in man. Br J Haematol 1967, 13(5):679-686.
43. Wright A.J., Finglas P.M., Dainty J.R., et al. Differential kinetic behavior and distribution for pteroylglutamic acid and reduced folates: A revised hypothesis of the primary site of PteGlu metabolism in humans. J Nutr 2005, 135(3):619-623.
44. King J.C. Effect of reproduction on the bioavailability of calcium, zinc, and selenium. J Nutr 2001, 131(4 suppl):1355S-1358S.
45. Krebs N.F. Bioavailability of dietary supplements and impact of physiologic state: Infants, children and adolescents. J Nutr 2001, 131(4 suppl):1351S-1354S.
46. Solomons N., Slavin J.L. What impact does stage of physiological development and/or physiological state have on the bioavailability of dietary supplements?. Summary of workshop discussion. J Nutr 2001, 131(4 suppl):1392S-1395S.
47. Winkels R.M., Brouwer I.A., Siebelink E., Katan M.B., Verhoef P. Bioavailability of food folates is 80% of that of folic acid. Am J Clin Nutr 2007, 85(2):465-473.
48. Pfeiffer C.M., Rogers L.M., Bailey L.B., Gregory J.F. Absorption of folate from fortified cereal-grain products and of supplemental folate consumed with or without food determined by using a dual-label stable-isotope protocol. Am J Clin Nutr 1997, 66(6):1388-1397.
49. USP34-NF29. The United States Pharmacopeial Convention 2011, 1292-1316. United Book Press, Inc, Baltimore, MD, 2911.
50. Special tabulations of data from Finer and Henshaw. Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspectives on Sexual and Reproductive Health 2006, 38:90-96. Accessed November 25, 2011. http://www.thenationalcampaign.org/resources/pdf/briefly-unplanned-in-the-united-states.pdf.